Federation des caisses Desjardins du Quebec’s Avidity Biosciences RNAM Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-165	Closed	-$7.19K	–	2984
2025 Q3	$7.19K	Hold	165	–	–	﹤0.01%	2363
2025 Q2	$4.69K	Hold	165	–	–	﹤0.01%	2274
2025 Q1	$4.87K	Hold	165	–	–	﹤0.01%	2174
2024 Q4	$4.8K	Hold	165	–	–	﹤0.01%	2096
2024 Q3	$7.58K	Hold	165	–	–	﹤0.01%	1973
2024 Q2	$6.74K	Hold	165	–	–	﹤0.01%	1901
2024 Q1	$4.21K	Hold	165	–	–	﹤0.01%	1998
2023 Q4	$1.49K	Hold	165	–	–	﹤0.01%	2110
2023 Q3	$1.05K	Hold	165	–	–	﹤0.01%	2147
2023 Q2	$1.83K	Hold	165	–	–	﹤0.01%	2067
2023 Q1	$2.53K	Hold	165	–	–	﹤0.01%	2052
2022 Q4	$3.66K	Hold	165	–	–	﹤0.01%	2091
2022 Q3	$2.69K	Hold	165	–	–	﹤0.01%	2213
2022 Q2	$2.4K	Hold	165	–	–	﹤0.01%	2284
2022 Q1	$3.05K	Hold	165	–	–	﹤0.01%	2304
2021 Q4	$3.92K	Hold	165	–	–	﹤0.01%	2252
2021 Q3	$4.06K	Hold	165	–	–	﹤0.01%	2301
2021 Q2	$4.08K	Hold	165	–	–	﹤0.01%	2300
2021 Q1	$3.6K	Buy	+165	New	+$4.04K	﹤0.01%	2262

Other funds holding RNAM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's RNAM Position: Q4 2025 in Review

Federation des caisses Desjardins du Quebec sold out of Avidity Biosciences (RNAM) in Q4 2025, closing a stake of 165 shares — an estimated $7.19K sold.

Federation des caisses Desjardins du Quebec first reported a position in RNAM in Q1 2021 and held it in 19 quarters. The position peaked at $7.58K in Q3 2024. 343 funds tracked by Wall St. Rank hold RNAM as of Q4 2025.

Federation des caisses Desjardins du Quebec reported no remaining Avidity Biosciences position as of Q4 2025 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 165 Avidity Biosciences shares in Q4 2025, an estimated $7.19K.
Federation des caisses Desjardins du Quebec first reported a position in Avidity Biosciences in Q1 2021 and held it in 19 quarters.
Federation des caisses Desjardins du Quebec's Avidity Biosciences position peaked at $7.58K in Q3 2024.
343 funds tracked by Wall St. Rank held Avidity Biosciences as of Q4 2025.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q4 2025, filed 12 Feb 2026.